Why Eli Lilly Stock Climbed to a Record High Today
Wall Street is getting more bullish on the pharma giant's shares.
Overview
Shares of Eli Lilly (NYSE: LLY) rose to a new all-time high on Tuesday, following upbeat analyst remarks.
Image source: Getty Images.
JPMorgan analyst Chris Schott reiterated his overweight (read: buy) rating on Eli Lilly's stock and boosted his share price target from $1,300 to $1,400.
Details
Source
Originally published at www.fool.com.
Related Articles
Disclaimer: This article is for informational purposes only and does not constitute investment advice. Data may be delayed up to 15 minutes. Past performance is not indicative of future results. Consult a licensed financial advisor before making investment decisions.